Drug Type Gene editing |
Synonyms AAV5 rhodopsin gene therapy (Precision Biosciences/University of North Carolina) |
Target |
Action modulators |
Mechanism RHO gene modulators(Rhodopsin gene modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinitis Pigmentosa | Preclinical | United States | - | |
Retinitis Pigmentosa | Preclinical | United States | - |